医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

China Must Ensure Safety Is Paramount in Biotech Push, says AHF

2023年04月15日 AM03:05
このエントリーをはてなブックマークに追加


 

LOS ANGELES

A Washington Post investigation has revealed an ambitious effort by China to expand its biotechnology sector significantly, with sometimes controversial research, to keep up with (or overtake) the U.S. and other Western powers while failing to ensure adequate safety measures kept pace. AIDS Healthcare Foundation (AHF) urges China or any nation conducting research with dangerous, highly-infectious pathogens to ensure the utmost security and oversight measures are implemented beforehand.

“The news of China’s move to dramatically increase its biotech sector, including genetic engineering, without first ensuring ample security measures is beyond worrisome – it’s irresponsible and potentially endangers everyone worldwide,” said Dr. Adele Schwartz Benzaken, AHF Senior Global Medical Director. “We implore China to do the right thing by ensuring an adequate portion of the billions of dollars it’s putting into increased laboratories, research, and experimental medicines goes to commensurate security that will bolster defenses against serious lab accidents – like the leaked bacteria that cause brucellosis in 2019 in Lanzhou and potentially SARS-CoV-2 in Wuhan the same year, which remains to be seen. The world cannot afford another pandemic unleashed upon it.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230414005345/en/

CONTACT

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work +1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

同じカテゴリーの記事 

  • NIPPON KINZOKU将在第十八届Medtec China上展出
  • Viromed Medical AG 计划通过增资与排除认购权的实物出资相结合的方式收购ActivCell Group AG的全部股份
  • Viromed Medical 、新株予約権を除く現物出資による増資でアクティブセル・グループの全株式取得を計画
  • NIPPON KINZOKU Exhibits at the “18th Medtec China”
  • SBC Medical Group Holdings and Pono Capital Two Announce Completion of Business Combination and Schedule to Begin Trading on the Nasdaq